Comparison of asthma exacerbations in pediatric and adult patients with severe or difficult-to-treat asthma

Journal of Allergy and Clinical Immunology

Volumn 124, Issue 5, 2009, Pages 1106-1108

  Zeiger, Robert S ^a   Chipps, Bradley E ^b   Haselkorn, Tmirah ^c   Rasouliyan, Lawrence ^d   Simons, F Estelle R ^e   Fish, James E ^c  

^a KAISER PERMANENTE   (United States)

^b Capital Allergy and Respiratory Disease Center   (United States)

^c GENENTECH INC   (United States)

^d ICON CLINICAL RESEARCH   (United States)

^e UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; PREDNISONE;

AIRFLOW; AIRWAY OBSTRUCTION; ASTHMA; DEMOGRAPHY; DISEASE EXACERBATION; DISEASE SEVERITY; EMERGENCY WARD; HOSPITALIZATION; HUMAN; LETTER; LONG TERM CARE; LUNG FUNCTION; PATIENT COMPLIANCE; PEDIATRICS; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SPIROMETRY; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; ASTHMA; CHILD; DISEASE PROGRESSION; HUMANS; YOUNG ADULT;

EID: 71749097174     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2009.07.052     Document Type: Letter

References (12)

1. The Childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med 343 (2000) 1054-1063
2. Dolan C.M., Fraher K.E., Bleecker E.R., Borish L., Chipps B., Hayden M.L., et al. TENOR Study Group. Design and baseline characteristics of The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma. Ann Allergy Asthma Immunol 92 (2004) 32-39
3. Skinner E.A., Diette G.B., Algatt-Bergstrom P.J., Nguyen T.T.H., Clark R.D., Markson L.E., et al. The Asthma Therapy Assessment Questionnaire (ATAQ) for children and adolescents. Disease Management 7 (2004) 305-313
4. Hankinson J.L., Odencrantz J.R., and Fedan K.B. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 159 (1999) 179-187
5. Bacharier L.B., Strunk R.C., Mauger D., White D., Lemanske Jr. R.F., and Sorkness C.A. Classifying asthma severity in children: mismatch between symptoms, medication use, and lung function. Am J Respir Crit Care Med 170 (2004) 426-432
6. Paull K., Covar R., Jain N., Gelfand E.W., and Spahn J.D. Do NHLBI lung function criteria apply to children? a cross-sectional evaluation of childhood asthma at National Jewish Medical and Research Center, 1999-2002. Pediatr Pulmonol 39 (2005) 311-317
7. Jenkins H.A., Cherniack R., Szefler S.J., Covar R., Gelfand E.W., and Spahn J.D. A comparison of the clinical characteristics of children and adults with severe asthma. Chest 124 (2003) 1318-1324
8. Leone F.T., Fish J.E., Szefler S.J., and West S.L. Systematic review of the evidence regarding potential complications of inhaled corticosteroid use in asthma: collaboration of American College of Chest Physicians, American Academy of Allergy, Asthma, and Immunology, and American College of Allergy, Asthma, and Immunology. Chest 124 (2003) 2329-2340
9. Zöllner E.W. Hypothalamic-pituitary-adrenal axis suppression in asthmatic children on inhaled corticosteroids (Part 2)-the risk as determined by gold standard adrenal function tests: a systematic review. Pediatr Allergy Immunol 18 (2007) 469-474
10. Kelly H.W., Van Natta M.L., Covar R.A., Tonascia J., Green R.P., and Strunk R.C. CAMP Research Group. Effect of long-term corticosteroid use on bone mineral density in children: a prospective longitudinal assessment in the childhood Asthma Management Program (CAMP) study. Pediatrics 122 (2008) 53-61
11. Rand C., Bilderback A., Schiller K., Edelman J.M., Hustad C.M., and Zeiger R.S. Adherence with montelukast or fluticasone in a long-term clinical trial: results from the mild asthma montelukast versus inhaled corticosteroid trial. J Allergy Clin Immunol 119 (2007) 916-923
12. Strunk R.C., Bacharier L.B., Phillips B.R., Szefler S.J., Zeiger R.S., Chinchilli V.M., et al. Azithromycin or montelukast as inhaled corticosteroid-sparing agents in moderate-to-severe childhood asthma study. J Allergy Clin Immunol 122 (2008) 1138-1144